Prognostic value of Annexin A3 in human colorectal cancer and its correlation with hypoxia-inducible factor-1α

Oncology Letters

Volumn 6, Issue 6, 2013, Pages 1631-1635

  Xie, Yong Qiu ^a   Fu, Di ^a   He, Zheng Hua ^a   Tan, Qing Dong ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Annexin A3; Colorectal cancer; Hypoxia inducible factor 1 ; Immunohistochemistry; Prognosis

Indexed keywords

GLYCEROPHOSPHOINOSITOL INOSITOLPHOSPHODIESTERASE; HYPOXIA INDUCIBLE FACTOR 1ALPHA;

ADULT; ARTICLE; CANCER MORTALITY; CANCER PROGNOSIS; CANCER STAGING; COLORECTAL CANCER; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PROTEIN EXPRESSION; SCORING SYSTEM; SURVIVAL RATE; TUMOR DIFFERENTIATION; TUMOR GROWTH; TUMOR VOLUME;

EID: 84886791143     PISSN: 17921074     EISSN: 17921082     Source Type: Journal    
DOI: 10.3892/ol.2013.1620     Document Type: Article

References (20)

1. Saif MW: Targeted agents for adjuvant therapy of colon cancer. Clin Colorectal Cancer 6: 46-51, 2006.
2. Raynal P and Pollard HB: Annexins: the problem of assessing the biological role for a gene family of multifunctional calcium-and phospholipid-binding proteins. Biochim Biophys Acta 1197: 63-93, 1994.
3. Gerke V and Moss SE: Annexins: from structure to function. Physiol Rev 82: 331-371, 2002.
4. Gerke V, Creutz CE and Moss SE: Annexins: linking Ca2+ signalling to membrane dynamics. Nat Rev Mol Cell Biol 6: 449-461, 2005.
5. Bai XF, Ni XG, Zhao P, et al: Overexpression of annexin 1 in pancreatic cancer and its clinical significance. World J Gastroenterol 10: 1466-1470, 2004.
6. Zimmermann U, Woenckhaus C, Teller S, et al: Expression of annexin AI in conventional renal cell carcinoma (CRCC) correlates with tumour stage, Fuhrman grade, amount of eosinophilic cells and clinical outcome. Histol Histopathol 22: 527-534, 2007.
7. Chen R, Brentnall TA, Pan S, et al: Quantitative proteomics analysis reveals that proteins differentially expressed in chronic pancreatitis are also frequently involved in pancreatic cancer. Mol Cell Proteomics 6: 1331-1342, 2007.
8. Esposito I, Penzel R, Chaib-Harrireche M, et al: Tenascin C and annexin II expression in the process of pancreatic carcinogenesis. J Pathol 208: 673-685, 2006.
9. Bae SM, Lee CH, Cho YL, et al: Two-dimensional gel analysis of protein expression profile in squamous cervical cancer patients. Gynecol Oncol 99: 26-35, 2005.
10. Domoto T, Miyama Y, Suzuki H, et al: Evaluation of S100A10, annexin II and B-FABP expression as markers for renal cell carcinoma. Cancer Sci 98: 77-82, 2007.
11. Wamunyokoli FW, Bonome T, Lee JY, et al: Expression profiling of mucinous tumors of the ovary identifies genes of clinicopathologic importance. Clin Cancer Res 12: 690-700, 2006.
12. Köllermann J, Schlomm T, Bang H, et al: Expression and prognostic relevance of Annexin A3 in prostate cancer. Eur Urol 54: 1314-1323, 2008.
13. Yan X, Yin J, Yao H, Mao N, Yang Y and Pan L: Increased expression of Annexin A3 is a mechanism of platinum resistance in ovarian cancer. Cancer Res 70: 1616-1624, 2010.
14. Tan Y, Meng HP, Teng FM, et al: Effect of miRNA interference to AnnexinA3 gene on growth of human gallbladder cancer cells. Chin Hepatobiliary Surg 16: 853-856, 2010 (In Chinese).
15. Katsuta M, Miyashita M, Makino H, et al: Correlation of hypoxia inducible factor-1alpha with lymphatic metastasis via vascular endothelial growth factor-C in human esophageal cancer. Exp Mol Pathol 78: 123-130, 2005.
16. Kimura S, Kitadai Y, Tanaka S, et al: Expression of hypoxia-inducible factor (HIF)-1alpha is associated with vascular endothelial growth factor expression and tumour angiogenesis in human oesophageal squamous cell carcinoma. Eur J Cancer 40: 1904-1912, 2004.
17. Kyzas PA, Stefanou D, Batistatou A and Agnantis NJ: Prognostic significance of VEGF immunohistochemical expression and tumor angiogenesis in head and neck squamous cell carcinoma. J Cancer Res Clin Oncol 131: 624-630, 2005.
18. Shibaji T, Nagao M, Ikeda N, et al: Prognostic significance of HIF-1 alpha overexpression in human pancreatic cancer. Anticancer Res 23: 4721-4727, 2003.
19. Park JE, Lee DH, Lee JA, et al: Annexin A3 is a potential angiogenic mediator. Biochim Biophys Res Com 337: 1283-1287, 2005.
20. Liu YF, Xiao ZQ, Li MX, et al: Quantitative proteome analysis reveals Annexin A3 as a novel biomarker in lung adenocarcinoma. J Pathol 217: 54-64, 2009.